The global bone growth stimulator market accounted to USD 1.01 billion in 2016 growing at a CAGR of 5.7% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Bone growth stimulator is a type of therapy which is utilized as a part of instances of delay or failure of fracture healing as they upgrade the bone-healing process without the vibe of electrical currents or vibrations when worn by the client in faster way. Bone development stimulators gadgets work by discharging either a low-level pulsed ultrasonic vitality or beat electromagnetic field as it helps in repairing the damaged tissues and cell formation.
Major market drivers and restraints:
- Rising preference towards non-invasive methods
- Growing investment opportunities
- Increasing number of patients related to bone related problems
On the basis of product, global bone growth stimulator market is segmented into device, boner morphogenetic protein and Platelet Rich Plasma (PRP). In 2016, the devices segment accounted the largest market share due to increase in rising population and non-surgical treatment methods.
On the basis of application, global bone growth stimulator market is segmented into spinal fusion, delay union & non-union bone fracture, and oral-maxillofacial. In 2016, spinal fusion segment has accounted the largest market share due to the continuous use of bone growth stimulator products and rise in aging population.
On the basis of end user, global bone growth stimulator market is segmented into hospitals, homecare, academia and CROs. Hospital segment is expected to witness the highest CAGR in the forecast period 2017-2024.
The global bone growth stimulator market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes bone growth stimulator market shares for global, Europe, North America, Asia Pacific, and South America.
Major Market Competitors:
Some of the major players of the bone growth stimulator market are Orthofix Holdings, Inc, Bioventus, DJO Finance LLC, Medtronic, Zimmer Biomet, Ossatec Benelux BV, IGEA S.p.A., Stryker, Arthrex, Inc., DePuySynthes Companies, elizur corporation, Isto Biologics, Ember Therapeutics, Altis Biologics, Regen Lab, SA., Verve Consulting, Smith & Nephew Plc., Harvest Technologies Corporation and Aetna, Inc. among others.
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.